Missouri Advances State-Licensed Cannabis Research Initiatives
State-licensed cannabis research programs in Missouri aim to accelerate clinical evidence generation by bypassing federal restrictions. These programs enable rigorous studies on cannabis efficacy and safety. Missouri's initiative could provide valuable…
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
The cannabis clinical scrutiny embraced by industry leaders marks a pivotal shift toward transparency and patient safety. This approach ensures clinicians have reliable data for evidence-based prescribing decisions. Cannabis clinical scrutiny benefits…
Hemp vs Weed? NJ Adjusts THC Rules Just Before 4/20. What to Know
NJ hemp THC rules 2026 introduce higher THC limits in hemp products, affecting clinical guidance on cannabis use. These changes create challenges in product labeling and potency consistency. Clinicians must understand NJ hemp THC rules 2026 to advise…
Cannabis Sales and Use Are High in Michigan – But Federal Law Means Research Lags Behind
Cannabis research barriers Michigan faces create challenges for clinicians advising patients. Federal restrictions limit clinical research despite high cannabis use. This gap impacts evidence-based guidance and patient safety.
Medical Cannabis Sales Market Analysis: Trends & Insights 2026
This article provides a detailed medical cannabis sales market analysis, focusing on application, type, and geographic trends. Clinicians can gain insights into evolving market dynamics in 2026. Understanding these trends supports informed decisions in…
Brain Signals May Reveal How Prospective Memory Falters in MCI — But Evidence Remains Preliminary
Prospective memory EEG ageing research explores how brain signals reveal memory changes in mild cognitive impairment (MCI). Healthy older adults may compensate neurally, while MCI patients show deficits. This study offers early insights into EEG markers…
Examining CBD Bioavailability Challenges and Precision Claims
CBD bioavailability challenges remain a significant barrier to precision delivery in cannabis therapeutics. Claims of precision CBD delivery require rigorous clinical evidence to ensure dosing consistency. Without peer-reviewed pharmacokinetic data,…
Impact of Preoperative Marijuana Use on Functional Recovery and Complications After Spinopelvic Fusion in Adult Spinal Deformity.
With the rising prevalence of marijuana use and increasing rates of complex spinal deformity surgeries, understanding the impact of preoperative marijuana use is critical. This study examines how preoperative marijuana use influences functional recovery…
Cannabidiol for Fibromyalgia: Clinical Trial Evidence and Analysis
This cannabidiol clinical trial fibromyalgia study found no superiority of CBD over placebo in reducing pain. The trial highlights the gap between patient use and clinical evidence. Clinicians should guide fibromyalgia patients based on evolving research.
1ml of RSO (~826mg THC) on a crunch bar. See ya!
When your edible dosing strategy requires a calculator and a signed waiver. Via r/trees Further Reading Evidence WatchMetformin reverses oxandrolone-induced anxiety-like behavior and amygdalar neurochemical dysregulation in male rats. Cannabis Policy…
